Does Melatonin Decrease Heart Rate?
Yes, melatonin does decrease heart rate, though the effect is generally modest and clinically significant primarily in specific contexts.
Cardiovascular Effects of Melatonin
The evidence consistently demonstrates that melatonin administration reduces heart rate in humans. Melatonin decreases heart rate by approximately 3-4 beats per minute in healthy individuals 1, 2. This effect occurs through modulation of cardiac autonomic activity, specifically by increasing cardiac vagal (parasympathetic) tone and potentially suppressing sympathetic activity 2.
Mechanism of Action
The heart rate reduction occurs via several pathways:
- Increased parasympathetic tone: Melatonin administration increases high-frequency power on heart rate variability analysis, indicating enhanced vagal activity 2
- Decreased sympathetic activity: Plasma norepinephrine and dopamine levels decrease following melatonin administration 2
- Autonomic rebalancing: The low-frequency to high-frequency ratio decreases, reflecting improved autonomic balance 2
Clinical Context and Magnitude
The heart rate reduction is:
- Dose-dependent: Studies show effects with doses ranging from 2-5 mg 1, 2, 3
- Position-dependent: The effect is most pronounced in the supine position and diminishes upon standing 2
- Time-dependent: Effects occur within 60 minutes of administration 2
- Generally modest: The 3-4 beat per minute reduction is statistically significant but typically not clinically concerning in healthy individuals 1
Important Clinical Considerations
A case report documents symptomatic bradycardia in a 22-year-old healthy male who took 20 mg of melatonin (well above typical doses), presenting with palpitations and dizziness 4. The bradycardia resolved spontaneously without intervention, but this highlights that higher doses can produce clinically significant effects.
Chronic Administration Effects
With chronic use (4 weeks), melatonin causes:
- Slight heart rate lowering during daytime hours (approximately 3 beats/minute reduction) 3
- Paradoxical heart rate acceleration during the second half of the night (mechanism unclear) 3
- Modest blood pressure reduction 3
Clinical Implications
Melatonin should be used cautiously in patients with:
- Pre-existing bradycardia or conduction abnormalities
- Concurrent use of beta-blockers or other heart rate-lowering medications 5
- Cardiovascular disease where heart rate changes could be problematic
The typical therapeutic dose of 2-4 mg administered 1-3 hours before bedtime 6 produces heart rate effects that are generally well-tolerated in healthy individuals but warrant monitoring in vulnerable populations.
Practical Recommendations
For clinical use:
- Start with lower doses (2-3 mg) to assess individual response 7, 6
- Administer 1-3 hours before desired sleep time 6
- Monitor heart rate in patients with cardiovascular risk factors
- Avoid doses exceeding 5 mg unless specifically indicated, as higher doses increase risk of symptomatic bradycardia 4
- Consider the interaction with medications that affect melatonin levels or heart rate 5
The heart rate reduction is part of melatonin's broader cardiovascular effects, which include blood pressure reduction and improved autonomic balance 8, 9, potentially offering cardiovascular benefits in hypertensive populations while requiring caution in those predisposed to bradycardia.